About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Evaluation of Repeat Administration of Purified Poloxamer 188

Evaluation of Repeat Administration of Purified Poloxamer 188

NCT02449616·9 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Mast Therapeutics, Inc.

Age

4–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Completed participation in study MST-188-01 (EPIC study)
Subject age 4 through 65 years
Subject is experiencing acute pain typical of VOC and requires treatment with parenteral opioid analgesia
Subject requires hospitalization

You may not be if

Subject has acute chest syndrome
Subject's laboratory results indicate inadequate organ function
Subject is pregnant or nursing an infant
Subject had a painful crisis requiring hospitalization within the preceding 14 days
Subject has been transfused within the past 14 days
Subject has complications related to SCD

The record

StatusCompleted

PhasePhase 3

Taking part16

StartedJun 2015

UpdatedOct 28, 2016

Conditions

Sickle Cell Disease

Where9

Rady Children's Hospital
San Diego, California, United States
Children's Hospital of Southwest Florida
Fort Myers, Florida, United States
Joe Dimaggio Children's Hospital
Hollywood, Florida, United States